[ Price : $8.95]
Eli Lilly recalls one lot of its Glucagon Emergency Kit for Low Blood Sugar after receiving a product complaint reporting that a v...[ Price : $8.95]
FDA accepts for review two Bristol Myers Squibb supplemental BLAs for Opdivo (nivolumab) in combination with Yervoy (ipilimumab) a...[ Price : $8.95]
FDA extends by three months the review of a Pfizer/Opko Health BLA for somatrogon, a once-weekly long-acting recombinant human gro...[ Price : $8.95]
Armstrong Medical recalls its Amsorb Plus Prefilled G-Can 1.0L due to reports that some canisters have difficulties with gas flow ...[ Price : $8.95]
Federal Register notice: FDA makes availability of an over-the-counter monograph proposed order entitled Amending Over-the-Counter...[ Price : $8.95]
Federal Register notice: FDA revokes the emergency use authorizations for three Covid-19 tests after the companies requested such ...[ Price : $8.95]
The CDER Office of Generic Drugs revises its scientific priorities as part of its user fee performance goals through 2022.[ Price : $8.95]
FDA approves an Amgen supplemental BLA for Repatha (evolocumab) injection as an add-on treatment to diet alone or together with ce...